LISCure Biosciences

Seongnam, South Korea · Founded 2018 · Privately Held (backing)

Developer of bacteria-mediated immunotherapy designed to treat tumors as well as cancer. LISCure Biosciences is based in Seongnam, South Korea and was founded in 2018. It has raised $47.5 million.

Last price · $/share
—
Implied valuation
—
Total raised
$47.5M
Last round
—

Who backs LISCure Biosciences?

18 investors
InvestorType
KB InvestmentVenture capital
Mayo ClinicOther
Yuanta InvestmentVenture capital
Shinhan SecuritiesOther
IBK SecuritiesOther
Roy Investment PartnersPE / buyout
HLB BioStep CompanyOther
CKD Bio—
Capital One—
DT & Investment—
+ 8 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

LISCure Biosciences investors

18 investors are on record for LISCure Biosciences, including KB Investment, Mayo Clinic, Yuanta Investment and Shinhan Securities.

Free account
More of LISCure Biosciences with a free account
  • ·The complete investor list: 18 names
  • ·Watch LISCure Biosciences: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 18 firms already write checks for companies like LISCure Biosciences. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View